Peggy Speight is a pharmaceutical quality assurance executive and compliance subject matter expert, with a strong record of leadership in both domestic and international regulatory environments. A trusted partner to any executive team that she partners with, Peggy is known for her strong ethics and integrity. Her leadership style is a combination of technical expertise and fine-tuned management skills which gives her an uncanny ability to engage clients and partners, alike. A mind for innovation, Peggy approaches every situation as if seeing for the first time, knowing that a fresh perspective inspires change and encourages growth.
Currently, she is the Vice President, Enterprise Regulatory Compliance at Johnson & Johnson, where she partners with senior leaders to provide strategy and framework to ensure a strong regulatory compliance profile. She was moved to join Johnson & Johnson in 2017, after learning about their strong commitment to patients, doctors and nurses, to mothers and fathers and all others who use their products and services. Also, their credo is deeply rooted in people and relationships – and seeing how those values inspired loyalty across the company. When she stepped into her role, surrounded by folks who had been at J&J for over 20 years, she knew that it mattered to prioritize intimately understanding the company from its history, to the products, processes, and relationships that would drive success. Currently, she is focused on how to best integrate lean thinking and principles, in addition to leading the Enterprise Independent Audit and External Manufacturer/Supplier Audit program, Enterprise Regulatory Outreach and Operationalization, Strategic Compliance Operations, Compliance Policy Management, the Office of Special Investigations, and Microbiological and Combination Products Regulatory Compliance.
Prior to joining Johnson and Johnson, Peggy held several positions with Bristol-Myers Squibb (BMS) including Executive Director, Quality Management Systems, Interim Site QA/QC Director, and Director of Global Internal/Supplier Audit Management Program. As a result of her strong leadership and exceptional performance, she won the BMS Achievement Award and was selected to participate in Women in Leadership (WINS), a development program for high-potentials. Prior to Bristol-Myers Squibb, Peggy held progressively senior Quality Assurance and Compliance positions at Endo Pharmaceuticals, including Director of Compliance overseeing the Global Internal/Supplier Audit Management Program. She began her career with the U.S. Food and Drug Administration, where she spent ten years as a Field Investigator and member of Team Biologics.
Peggy’s impact reaches far beyond the walls of her office. She is a board member at Rx360, a nonprofit international consortium that addresses pharmaceutical and medical device supply chain security in relation to public health concerns and patient safety. In addition, she is a member of Global Benchmarking Group and Advancing Women Executives, an organization with the mission to create greater equity and economic growth in the workplace. When she’s not at work, Peggy can be found mentoring youth and young adults.
Peggy completed her Master’s in Health Administration at Hofstra University and her Bachelor’s of Science in Health Administration from S.U.N.Y Brockport.